SCHEMBL2209498

SCHEMBL2209498

COc1cc(N2CCN(C(C)C)CC2)ccc1N.COc1cc(N2CCN(C(C)C)CC2)ccc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 2/20 0.49
MAPT P10636 2/20 0.49
PKM P14618 1/20 0.49
FYN P06241 1/20 0.48
TGFBR1 P36897 2/20 0.47
ACVR1 Q04771 2/20 0.47
KCNH2 Q12809 1/20 0.47
ALK Q9UM73 2/20 0.46
TLR9 Q9NR96 3/20 0.44
TLR7 Q9NYK1 3/20 0.44
TLR8 Q9NR97 2/20 0.44
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
KHK P50053 1/20 0.43
SUV39H2 Q9H5I1 1/20 0.43
IGF1R P08069 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310368 1.00 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL2204683 0.94 CHEK1 (0.46) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL15358736 0.89 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTPKMCYP3A4
SCHEMBL2206359 0.88 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL517509 0.87 VCP (0.43) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL13362045 0.86 MAPT (0.41) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL24625573 0.84 MAPT (0.45) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL309692 0.84 MAPT (0.47) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL1911903 0.83 TGFBR1 (0.51) ALDH1A1KDM4EMAPTPKMFYN
SCHEMBL3309196 0.83 GAA (0.40) ALDH1A1KDM4EMAPTFYNTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981903-B2 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer GLAXOSMITHKLINE LLC (US) 2011-07-19 US disclosed
US-20100204196-A1 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer GLAXOSMITHKLINE LLC 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204196-A1 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer IGF1R, IGFBP2, IGFBP1 ALDH1A1 378/4885KDM4E 1487/4885MAPT 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.